Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Delayed- versus acute-onset endophthalmitis after cataract surgery.

Shirodkar AR, Pathengay A, Flynn HW Jr, Albini TA, Berrocal AM, Davis JL, Lalwani GA, Murray TG, Smiddy WE, Miller D.

Am J Ophthalmol. 2012 Mar;153(3):391-398.e2. doi: 10.1016/j.ajo.2011.08.029. Epub 2011 Oct 25.

2.

Endophthalmitis after intravitreal vascular [corrected] endothelial growth factor antagonists: a six-year experience at a university referral center.

Moshfeghi AA, Rosenfeld PJ, Flynn HW Jr, Schwartz SG, Davis JL, Murray TG, Smiddy WE, Berrocal AM, Dubovy SR, Lee WH, Albini TA, Lalwani GA, Kovach JL, Puliafito CA.

Retina. 2011 Apr;31(4):662-8. doi: 10.1097/IAE.0b013e31821067c4. Erratum in: Retina. 2012 Jul;32(7):1441.

PMID:
21836400
3.

The comparison of clinical outcomes of endophthalmitis from fluoroquinolone-resistant and susceptible bacteria.

Shirodkar AR, Flynn HW, Alliman K, Lalwani GA, Alabiad C, Moshfeghi AA, Miller D.

Clin Ophthalmol. 2010 Apr 26;4:211-4.

4.

A variable-dosing regimen with intravitreal ranibizumab for neovascular age-related macular degeneration: year 2 of the PrONTO Study.

Lalwani GA, Rosenfeld PJ, Fung AE, Dubovy SR, Michels S, Feuer W, Davis JL, Flynn HW Jr, Esquiabro M.

Am J Ophthalmol. 2009 Jul;148(1):43-58.e1. doi: 10.1016/j.ajo.2009.01.024. Epub 2009 Apr 18.

PMID:
19376495
5.

Off-label use of intravitreal bevacizumab (Avastin) for salvage treatment in progressive threshold retinopathy of prematurity.

Lalwani GA, Berrocal AM, Murray TG, Buch M, Cardone S, Hess D, Johnson RA, Puliafito CA.

Retina. 2008 Mar;28(3 Suppl):S13-8. doi: 10.1097/IAE.0b013e3181644ad2. Erratum in: Retina. 2009 Jan;29(1):127.

PMID:
18317338
6.

Macular thickness measurements in normal eyes using spectral domain optical coherence tomography.

Legarreta JE, Gregori G, Punjabi OS, Knighton RW, Lalwani GA, Puliafito CA.

Ophthalmic Surg Lasers Imaging. 2008 Jul-Aug;39(4 Suppl):S43-9.

PMID:
18777876
7.

Three-dimensional spectral-domain optical coherence tomography images of the retina in the presence of epiretinal membranes.

Legarreta JE, Gregori G, Knighton RW, Punjabi OS, Lalwani GA, Puliafito CA.

Am J Ophthalmol. 2008 Jun;145(6):1023-1030. doi: 10.1016/j.ajo.2008.01.014. Epub 2008 Mar 14.

PMID:
18342830
8.

Acute-onset endophthalmitis after clear corneal cataract surgery (1996-2005). Clinical features, causative organisms, and visual acuity outcomes.

Lalwani GA, Flynn HW Jr, Scott IU, Quinn CM, Berrocal AM, Davis JL, Murray TG, Smiddy WE, Miller D.

Ophthalmology. 2008 Mar;115(3):473-6. Epub 2007 Dec 11.

PMID:
18067969
9.

Documentation of optic nerve pit with macular schisis-like cavity by spectral domain OCT.

Lalwani GA, Punjabi OS, Flynn HW Jr, Knighton RW, Puliafito CA.

Ophthalmic Surg Lasers Imaging. 2007 May-Jun;38(3):262-4.

PMID:
17552399
10.

An optical coherence tomography-guided, variable dosing regimen with intravitreal ranibizumab (Lucentis) for neovascular age-related macular degeneration.

Fung AE, Lalwani GA, Rosenfeld PJ, Dubovy SR, Michels S, Feuer WJ, Puliafito CA, Davis JL, Flynn HW Jr, Esquiabro M.

Am J Ophthalmol. 2007 Apr;143(4):566-83.

PMID:
17386270
11.

Ranibizumab: Phase III clinical trial results.

Rosenfeld PJ, Rich RM, Lalwani GA.

Ophthalmol Clin North Am. 2006 Sep;19(3):361-72. Review.

PMID:
16935211
12.

Short-term safety and efficacy of intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration.

Rich RM, Rosenfeld PJ, Puliafito CA, Dubovy SR, Davis JL, Flynn HW Jr, Gonzalez S, Feuer WJ, Lin RC, Lalwani GA, Nguyen JK, Kumar G.

Retina. 2006 May-Jun;26(5):495-511.

PMID:
16770255

Supplemental Content

Loading ...
Support Center